STOCK TITAN

Opus Genetics: Boxer reports 5.4% passive stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Opus Genetics, Inc. (IRD): Boxer Capital Management, LLC, Boxer Holdings, LP, Boxer Holdings GP, LLC, and Aaron Davis each reported beneficial ownership of 4,533,660 shares, or 5.4%, as of September 30, 2026. The percentage was based on 83,195,823 Opus Genetics shares outstanding as of August 3, 2026.

Beneficially owned shares 4,533,660 shares Each of the four reporting persons reported this amount as of September 30, 2026; the repeated amounts are not additive.
Percent of class 5.4% Reported by each reporting person as of September 30, 2026.
Shares outstanding 83,195,823 shares As of August 3, 2026; used as the basis for the reported ownership percentage.
beneficially owned regulatory
"Amount beneficially owned"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Shared Voting Power regulatory
"Shared Voting Power 4,533,660.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power regulatory
"Shared Dispositive Power 4,533,660.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Opus Genetics (IRD) shares did the reporting persons report owning?

Each of the four reporting persons reported beneficial ownership of 4,533,660 shares, or 5.4%, as of September 30, 2026. The percentage was based on 83,195,823 Opus Genetics shares outstanding as of August 3, 2026.

Who has voting power over the reported Opus Genetics (IRD) shares?

Each reporting person listed shared voting power and shared dispositive power over 4,533,660 shares, with zero sole voting power and zero sole dispositive power.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





67577R102

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Boxer Capital Management, LLC
Signature:/s/ Aaron Davis
Name/Title:Boxer Capital Management, LLC, by Aaron Davis its Manager
Date:11/13/2026
Boxer Holdings, LP
Signature:/s/ Aaron Davis
Name/Title:Boxer Holdings, LP, by Boxer Holdings GP, LLC, its General Partner, by Aaron Davis its Manager
Date:11/13/2026
Boxer Holdings GP, LLC
Signature:/s/ Aaron Davis
Name/Title:Boxer Holdings GP, LLC by Aaron Davis, its Manager
Date:11/13/2026
Aaron Davis
Signature:/s/ Aaron Davis
Name/Title:Aaron Davis, an individual
Date:11/13/2026

Keep reading